Stockscreener 앱 받기
44.41
1.49%
0.65
시장 영업 전:
45.00
0.59
+1.33%
전일 마감가:
$43.76
열려 있는:
$44.01
하루 거래량:
281.63K
Relative Volume:
0.49
시가총액:
$2.02B
수익:
$1.23B
순이익/손실:
$20.43M
주가수익비율:
100.68
EPS:
0.4411
순현금흐름:
$95.39M
1주 성능:
+2.99%
1개월 성능:
+21.17%
6개월 성능:
+23.36%
1년 성능:
+53.99%
1일 변동 폭
$43.91
$44.66
1주일 범위
$42.46
$45.00
52주 변동 폭
$26.84
$55.00
옴니셀 Stock (OMCL) Company Profile
명칭
Omnicell Inc
전화
(877) 415-9990
주소
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, BTSG, TEM, HQY, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
44.41 | 1.99B | 1.23B | 20.43M | 95.39M | 0.4411 |
VEEV
Veeva Systems Inc
|
160.17 | 25.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
58.50 | 11.25B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.18 | 8.35B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.11 | 7.25B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
55.25 | 4.27B | 646.34M | -512.40M | 202.76M | -6.6871 |
옴니셀 Stock (OMCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2026-01-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-02 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-01-03 | 개시 | Barclays | Underweight |
| 2023-11-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-11-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | 재확인 | Wells Fargo | Underweight |
| 2023-08-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-11-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | 개시 | BofA Securities | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Mkt Perform |
| 2021-12-06 | 재개 | Wells Fargo | Overweight |
| 2021-06-09 | 개시 | JP Morgan | Neutral |
| 2021-05-24 | 개시 | BTIG Research | Buy |
| 2021-02-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-12-03 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-02-07 | 재확인 | Dougherty & Company | Buy |
| 2019-11-21 | 재확인 | Dougherty & Company | Buy |
| 2019-07-26 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-03-07 | 재확인 | Dougherty & Company | Buy |
| 2018-06-29 | 재개 | The Benchmark Company | Buy |
| 2017-09-05 | 재확인 | The Benchmark Company | Buy |
| 2017-07-28 | 재확인 | Dougherty & Company | Buy |
| 2017-04-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | 개시 | Dougherty & Company | Buy |
| 2016-12-06 | 재확인 | The Benchmark Company | Buy |
| 2016-07-07 | 재확인 | FBR Capital | Outperform |
| 2016-03-21 | 재확인 | Topeka Capital Markets | Buy |
| 2016-01-07 | 개시 | The Benchmark Company | Buy |
| 2015-11-16 | 재확인 | Topeka Capital Markets | Buy |
| 2015-10-30 | 재확인 | FBR Capital | Outperform |
| 2015-09-28 | 업그레이드 | Sidoti | Neutral → Buy |
| 2015-07-31 | 재확인 | Topeka Capital Markets | Buy |
모두보기
옴니셀 주식(OMCL)의 최신 뉴스
Understanding Momentum Shifts in (OMCL) - Stock Traders Daily
Omnicell Stock Surges 57.3% in a Year: What's Driving It? - TradingView
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch - Yahoo Finance
Omnicell, Inc.Common Stock (NQ: OMCL - The Chronicle-Journal
Should You Buy Omnicell (OMCL) After Golden Cross? - Yahoo Finance
Why Omnicell Stock Crushed the Market Today - MSN
Omnicell Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Omnicell (OMCL) Issues Recall for Specific Syringe Labels - GuruFocus
Which Is a Better Investment, Axogen, Inc. or Omnicell, Inc. Stock? - AAII
How Much Upside is Left in Omnicell (OMCL)? Wall Street Analysts Think 39.87% - Yahoo Finance
Omnicell EVP Corey Manley sells $217,180 in OMCL shares By Investing.com - Investing.com South Africa
Omnicell EVP Corey Manley sells $217,180 in OMCL shares - Investing.com
Omnicell (OMCL) COO reports 3,090-share sale and RSU tax withholding - Stock Titan
Omnicell (OMCL) officer has 226 shares withheld to cover RSU taxes - Stock Titan
Omnicell (OMCL) EVP Manley sells 5,025 shares, 4,041 withheld for taxes - Stock Titan
Omnicell (OMCL) CEO uses 12,347 shares to cover RSU tax withholding - Stock Titan
Is Analyst Optimism And Wellington’s Stake Reshaping The Investment Case For Omnicell (OMCL)? - Sahm
OMCL (NASDAQ) director files to sell 5,025 vested shares via Fidelity - Stock Titan
[144] OMNICELL, INC. SEC Filing - Stock Titan
Dana Investment Advisors Inc. Purchases New Shares in Omnicell, Inc. $OMCL - MarketBeat
Omnicell Inc stock (US6821321088): pharmacy automation specialist after latest earnings update - AD HOC NEWS
Omnicell Stock Analysis: Is It a Buy or a Portfolio Risk After 23% Gain?News and Statistics - IndexBox
Omnicell (OMCL) is a great momentum stock: Should you buy? - MSN
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead - Yahoo Finance
Wellington affiliates hold 5.96% of Omnicell (OMCL) common stock - Stock Titan
OMCL News | OMNICELL INC (NASDAQ:OMCL) - ChartMill
Avoiding Lag: Real-Time Signals in (OMCL) Movement - Stock Traders Daily
Here is What Analysts Are Saying About Omnicell, Inc. (OMCL) - Insider Monkey
What is Zacks Research's Estimate for Omnicell Q2 Earnings? - MarketBeat
Omnicell's (NASDAQ:OMCL) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
Omnicell's (NASDAQ:OMCL) Conservative Accounting Might Explain Soft Earnings - simplywall.st
Some Investors May Be Willing To Look Past Omnicell's (NASDAQ:OMCL) Soft Earnings - 富途牛牛
BofA Securities Maintains Omnicell(OMCL.US) With Buy Rating, Maintains Target Price $70 - Moomoo
What Can You Expect From Omnicell Inc (OMCL) Stock After Solid Q1? - Insider Monkey
Omnicell (NASDAQ:OMCL) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
Omnicell lifts 2026 non-GAAP EPS outlook to $1.80-$2.00 as Titan XT shipments are planned for 2H 2026 - MSN
Q3 2025 Omnicell Inc Earnings Call Transcript - GuruFocus
Q2 2025 Omnicell Inc Earnings Call Transcript - GuruFocus
Vanguard Group Inc. Has $251.55 Million Holdings in Omnicell, Inc. $OMCL - MarketBeat
Here's why Omnicell (OMCL) is a strong momentum stock - MSN
Pharmacy Automation Systems Market to Get an Explosive Growth | - openPR.com
Is It Time To Reassess Omnicell (OMCL) After Its 71% One Year Share Price Rebound - Yahoo Finance
Omnicell Names Former KU Health System Exec as Its Chief Pharmacy and Clinical Officer - Dallas Innovates
Here's Why Omnicell (OMCL) is a Strong Momentum Stock - Yahoo Finance
Omnicell (NASDAQ: OMCL) returns to profit with stronger Q1 2026 cash flow - Stock Titan
Omnicell | 10-Q: Q1 2026 Earnings Report - Moomoo
Wall Street analysts see a 41.19% upside in Omnicell (OMCL): Can the stock really move this high? - MSN
Omnicell (OMCL) Q1 2026 Earnings Transcript - AOL.com
Omnicell, Inc. Experiences Valuation Adjustment Amid Strong Market Performance Metrics - Markets Mojo
Omnicell (OMCL) Is Up 13.7% After Earnings Beat, Raised Guidance, And Key Pharmacy HireWhat's Changed - Sahm
North America Central Fill Pharmacy Automation Market Growth - openPR.com
옴니셀 (OMCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
옴니셀 주식 (OMCL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Manley Corey J | EVP&CHIEF LEGAL/ADMIN OFFICER |
May 18 '26 |
Sale |
43.22 |
5,025 |
217,180 |
112,783 |
0.66%
4.05%
자본화:
|
볼륨(24시간):